Ask AI

ClinicalThought

Share

Program Content

Activities

  • FAQs: Biomarker Testing in NSCLC
    FAQs: Importance of Biomarker Testing in NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 31, 2022

  • NSCLC: Current and Emerging Testing
    What Must Be Tested in NSCLC Today and Likely Tomorrow
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 11, 2022

  • NSCLC: Trastuzumab Deruxtecan
    Trastuzumab Deruxtecan for Our Patients With HER2 Mutation–Positive Advanced NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 12, 2022

  • NSCLC: Experts Address FAQs
    FAQs: New Directions in Biomarker Testing in the Management of NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 17, 2022

Provided by

ProCE Banner

Supporters

AstraZeneca

Bayer Healthcare Pharma

Daiichi Sankyo, Inc.

Genentech

Janssen administered by Scientific Affairs

Lilly

Novartis Pharmaceuticals Corporation

Partners

AMP

ProCE Banner